| Report ID | 279190 |
| Drug Identification Number | 02357631 |
| Brand name | VIMPAT |
| Common or Proper name | Vimpat 150mg tablets |
| Company Name | UCB CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LACOSAMIDE |
| Strength(s) | 150MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 60 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2026-03-06 |
| Actual start date | |
| Estimated end date | 2026-03-20 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-02-27 |
| Company comments | Short terms OOS. Product ready to ship from USA. Will ship as soon as DEA export approval is received. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2201 BRISTOL CIRCLE OAKVILLE, ONTARIO CANADA L6H 0J8 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-02-27 | French | Compare |
| v1 | 2026-02-27 | English | Compare |
Showing 1 to 2 of 2